Abstract
Background
Leptospirosis has been implicated as a severe and fatal form of disease in Mayotte, a French-administrated territory located in the Comoros archipelago (southwestern Indian Ocean). To date, Leptospira isolates have never been isolated in this endemic region.
Methods and Findings
Leptospires were isolated from blood samples from 22 patients with febrile illness during a 17-month period after a PCR-based screening test was positive. Strains were typed using hyper-immune antisera raised against the major Leptospira serogroups: 20 of 22 clinical isolates were assigned to serogroup Mini; the other two strains belonged to serogroups Grippotyphosa and Pyrogenes, respectively. These isolates were further characterized using partial sequencing of 16S rRNA and ligB gene, Multi Locus VNTR Analysis (MLVA), and pulsed field gel electrophoresis (PFGE). Of the 22 isolates, 14 were L. borgpetersenii strains, 7 L. kirschneri strains, and 1, belonging to serogoup Pyrogenes, was L. interrogans. Results of the genotyping methods were consistent. MLVA defined five genotypes, whereas PFGE allowed the recognition of additional subgroups within the genotypes. PFGE fingerprint patterns of clinical strains did not match any of the patterns in the reference strains belonging to the same serogroup, suggesting that the strains were novel serovars.
Conclusions
Preliminary PCR screening of blood specimen allowed a high isolation frequency of leptospires among patients with febrile illness. Typing of leptospiral isolates showed that causative agents of leptospirosis in Mayotte have unique molecular features.
Author Summary
Leptospirosis has been recognized as an increasing public health problem affecting poor people from developing countries and tropical regions. However, the epidemiology of leptospirosis remains poorly understood in remote parts of the world. In this study of patients from the island of Mayotte, we isolated 22 strains from the blood of patients during the acute phase of illness. The pathogenic Leptospira strains were characterized by serology and various molecular typing methods. Based on serological data, serogroup Mini appears to be the dominant cause of leptospirosis in Mayotte. Further molecular characterization of these isolates allowed the identification of 10 pathogenic Leptospira genotypes that could correspond to previously unknown serovars. Further progress in our understanding of the epidemiology of Leptospira circulating genotypes in highly endemic regions should contribute to the development of novel strategies for the diagnosis and prevention of this neglected emerging disease.
Introduction
Leptospirosis, a zoonotic disease with a worldwide distribution, is an important emerging infectious disease [1]. Rodents are a main reservoir of the pathogenic agents of this disease, spirochetes of the genus Leptospira, excreting the bacteria in their urine. Humans are usually infected through contaminated water. This increasingly common disease affects impoverished populations from developing countries and tropical regions [2]. Leptospirosis is an endemic disease in rural regions of developing countries because of the exposure to a large number of animal reservoirs [3], [4]. Furthermore leptospirosis is an emerging health problem in urban slums where inadequate sanitation has produced the conditions for rat-borne transmission of the disease [5], [6], [7]. Outbreaks of leptospirosis are associated with heavy seasonal rainfall [5], [8], [9], [10] and extreme climatic events, such as hurricanes [6], [11] and El Niño [12], [13]. Over the last decade, outbreaks of leptospirosis were also associated to adventure tourism [14], [15]. More than 500,000 cases of severe leptospirosis are currently reported each year, with case fatality rates exceeding 10% [16]. However, its prevalence is still underestimated due to low awareness among the medical community and an absence of specific symptoms and readily available tests. In addition, some patients may also experience transient or mild manifestations [2].
Mayotte is a French-administrated territory located northwest of Madagascar in the Comoros archipelago, southwestern Indian Ocean ( Figure 1A ). The climate of this volcanic island is generally tropical and mild. The estimated population in 2007 was 186,387. The population is primarily of African origin. Unemployment is high and 39% of the population consists of immigrants from the neighboring Comoro Islands. Many of the inhabitants rear dairy herds and/or cultivate rice, cassava roots (manioc), maize, bananas or pineapples. Most households lack proper sanitation.
Leptospirosis is endemic in Mayotte [17]. The annual incidence of leptospirosis was previously estimated to be 3.8 patients per 100,000 individuals between 1984 and 1989 [17]. In 2008 and 2009, the annual incidence rate was estimated to be 45 patients per 100,000 individuals.
Leptospires are usually classified into species and serovars or serogroups. There are over 200 recognized pathogenic serovars; these serovars are currently clustered into 24 serogroups [1], [18], [19]. There have been no extensive studies on leptospiral serovars obtained from humans in Mayotte. Hence, we investigated the serological and genetic characteristics of leptospiral isolates isolated from leptospirosis patients in 2007–2008. Twenty-two plasma samples from heparinized blood specimens of individuals with leptospirosis-like illness testing positive for Leptospira spp. by PCR, were cultured and characterized by serology, sequencing of 16S RNA and ligB, and pulsed field gel electrophoresis (PFGE). In this study, our approach allowed a high rate of isolation of Leptospira from patients. We also report the existence of ten potentially new pathogenic Leptospira genotypes, which cause acute leptospirosis in Mayotte.
Methods
Isolation procedure of Leptospira spp
Blood samples (heparinized blood for culture and EDTA plasma for DNA extraction) were obtained from patients during the acute phase of illness (fever of 38°C or higher for no more than 7 days, accompanied by headache and/or myalgia) after oral assent after reading a script, which was approved by the Ethical Committee of the Centre Hospitalier de Mayotte, that informed of the possible use of blood samples for scientific purpose. Informed consent was recorded in writing in the patient's file as required by the Ethical Committee.
Ten drops (250 µl) and 20–40 drops (500–1000 µl) of plasma from heparinized blood were transferred into two tubes containing 9 ml of EMJH liquid medium [20], [21]. Cultures were incubated at 30°C and examined weekly, for 3 months, by dark field microscopy. In case of contamination, cultures were filtered through 0.22 µm pores to remove contaminants. Reference strains were obtained from the collection maintained by the National Reference Laboratory for Leptospira, which is also a WHO Collaborating Center, at the Institut Pasteur (Paris, France).
Serogrouping
Serological characterization of clinical isolates was performed at the National Reference Center for Leptospira. A Microscopic agglutination test (MAT) was performed to determine the serogroup of Leptospira isolates using rabbit antisera against reference serovars representing a standard battery of 24 serogroups (Text S1). High rates of agglutination of the serum with one particular antigen are used to identify the presumptive serogroup of the infecting bacterium [22].
Animal experiments
To determine if clinical isolates would induce an infection in laboratory animals, a group of four 28-day-old gerbils (Charles River Laboratories, http://www.criver.com) were inoculated intraperitoneally with 101, 102, 103, 104, and 106 leptospires from strain 2007/01203. A group of control was also inoculated with EMJH medium. Animals were monitored daily for clinical signs of leptospirosis (i.e., prostration, jaundice, etc) and survival for up to 21 days post infection. Protocols for animal experiments were prepared according to the guidelines of the Animal Care and Use Committees of the Institut Pasteur.
Histopathologic analysis was perfomed after necropsy of infected animals which received 104 leptospires at the day of death (6 or 7 days post -inoculation) and non infected animals. Liver, kidneys, and lungs were removed and fixed in 4% buffered formaldehyde for standard microscopic analysis; serial sections were stained with hematoxylin and eosin (HE) and Warthin–Starry silver impregnation as previously described [23]. The pathologist viewed the histopathological preparations without knowing the infection status of the animals.
DNA manipulations
Genomic DNA was extracted from 400 µl of EDTA plasma using a MagNaPure Compact instrument (Roche Molecular Diagnostics), and yielded 50 µl of eluate. Leptospires in plasma were detected by quantitative real-time PCR (qPCR) using the Light cycler LC480 system (Roche) or the Cobas TacMan 48 system (Roche) as previously described [24]. A standard curve with DNA extracted from 10-fold dilutions of known numbers of leptospires was used for quantification. Samples with a threshold cycle (Ct) value >45 were considered negative. However, patient 13 with a Ct of 44.7 ( Table 1 ) close to the cutoff was also included in this study.
Table 1. List of clinical isolates from Mayotte tested in this study.
patient | sex (M/F) | age (years) | Location | sampling date | Ct c | bacteria/ml | strain | MAT d | Species e | ligB | VNTR | PFGE f | ||||
4 | 7 | 10 | Lb4 | Lb5 | ||||||||||||
Patient 1 a | M | 58 | Dembeni | May 2007 | 28 | 1,0E+05 | 2007/01203 g | Mn 6,400 | L. borgpetersenii | A | 1 | - | 1 | 4 | 5 | I |
Patient 2 b | M | 23 | Chiconi | Apr. 2007 | 34.9 | 6,7E+02 | 2007/01204 | Mn 6,400 | L. borgpetersenii | A | 1 | - | 1 | 4 | 5 | I |
Patient 3 b | M | 21 | Ouangani | May 2007 | 35.9 | 3,3E+02 | 2007/01473 | Mn 3,200 Hb 800 | L. borgpetersenii | A | 1 | - | 1 | 4 | 5 | I |
Patient 4 b | M | 20 | Bandraboua | Feb. 2008 | 34.9 | 6,7E+02 | 2008/01285 | Mn 3,200 | L. borgpetersenii | A | 1 | - | 1 | 4 | 5 | I |
Patient 5 | F | 22 | Mamoudzou | Feb. 2008 | 31.3 | 9,2E+03 | 2008/01286 | Mn 3,200 | L. borgpetersenii | A | 1 | - | 1 | 4 | 5 | I |
Patient 6 a | M | 36 | Dembeni | Feb 2008 | 25.2 | 7,7E+05 | 2008/01287 | Mn 3,200 | L. borgpetersenii | A | 1 | - | 1 | 4 | 5 | I |
Patient 7 b | M | 23 | Dembeni | Mar. 2008 | 28.1 | 9,3E+04 | 2008/01593 | Mn 3,200 | L. borgpetersenii | A | 1 | - | 1 | 4 | 5 | I |
Patient 8 | F | 25 | Chiconi | Mar. 2008 | 30.9 | 1,2E+04 | 2008/01594 | Mn 6,400 | L. borgpetersenii | A | 1 | - | 1 | 4 | 5 | I |
Patient 9 | M | 32 | Mamoudzou | Apr 2008 | 31.2 | 9,8E+03 | 2008/01924 | Mn 12,800 | L. borgpetersenii | A | 1 | - | 1 | 4 | 5 | I |
Patient 10 | M | 39 | Chiconi | Apr. 2008 | 30.9 | 1,2E+04 | 2008/01931 | Mn 800 | L. borgpetersenii | A | 1 | - | 1 | 4 | 5 | I |
Patient 11 | M | 59 | Chiconi | Jun. 2008 | 33.9 | 1,4E+03 | 2008/02842 | Mn 12,800 Hb 800 | L. borgpetersenii | A | 1 | - | 1 | 4 | 5 | I |
Patient 12 | M | 20 | Chirongui | Apr. 2008 | 38.1 | 6,6E+01 | 2008/01773 | Mn 400 | L. borgpetersenii | B | 1 | - | 1 | 8 | 5 | II |
Patient 13 | M | 78 | Mtsamboro | Apr. 2008 | 44.7 | <1 | 2008/01929 | Mn 400 | L. borgpetersenii | B | 1 | - | 1 | 8 | 5 | II |
Patient 14 b | M | 29 | Tsingoni | Apr. 2008 | 37.9 | 7,6E+01 | 2008/01927 | Mn 800 | L. borgpetersenii | B | 1 | - | 1 | 8 | 5 | III |
Patient 15 | M | 13 | Chirongui | Apr. 2008 | 40.9 | 8,6E+00 | 2008/01926 | Mn 800 | L. kirschneri | C | 0 | 2 | 1 | ND | ND | IV |
Patient 16 | M | 45 | Sada | May 2008 | 37.5 | 1,0E+02 | 2008/02843 | Mn 6,400 Hb 1,600 | L. kirschneri | C | 0 | 2 | 1 | ND | ND | V |
Patient 17 | F | 33 | Tsingoni | Mar. 2008 | 35.7 | 3,8E+02 | 2008/01925 | Mn 3,200 | L. kirschneri | C | 0 | 2 | 1 | ND | ND | V |
Patient 18 | M | 26 | Dembeni | Dec 2007 | 38.3 | 5,7E+01 | 2008/00695 | Mn 3,200 Hb 200 | L. kirschneri | C | 0 | 2 | 1 | ND | ND | VI |
Patient 19 | F | 29 | Bandraboua | Apr. 2008 | 37.4 | 9,5E+01 | 2008/02841 | Mn 6,400 Hb 6,400 | L. kirschneri | C | 0 | 2 | 1 | ND | ND | VII |
Patient 20 b | M | 52 | Pamandzi h | Sep. 2008 | 37.6 | 1,1E+02 | 2008/03703 | Mn 3,200 Hb 3,200 | L. kirschneri | C | 0 | 2 | 1 | ND | ND | VIII |
Patient 21 | M | 20 | Tsingoni | Jan. 2008 | 40.6 | 1,1E+01 | 2008/01774 | Gp 3,200 | L. kirschneri | C | 0 | 3 | 9 | ND | ND | IX |
Patient 22 | F | 39 | Mtsamboro | June 2007 | 30.6 | 1,5E+04 | 2007/01872 | Pyr 1,600 | L. interrogans | D | 6 | 10 | 6 | ND | ND | X |
ND: not determined.
a: lethal case associated with jaundice and acute renal failure.
b: patient with reported contact with water (swimming in a river) and/or animals (rats, dogs, cattle).
c: threshold cycle (Ct) value obtained by Real-Time PCR of DNA extracted from plasma samples.
d: Pyr, Pyrogenes; Mn, Mini; Hb, Hebdomadis (see Text S1 for the list of antisera used for serogrouping).
e: determined by 16S rRNA sequencing.
f: Pulsed field Gel Electrophoresis (PFGE) analysis with NotI.
h: probable acquisition of leptospirosis in Madagascar (see Discussion).
Genomic DNA was extracted from EMJH cultures using the Cell DNA Purification kit (Maxwell, Promega, Madison, WI). DNA was amplified using Taq polymerase (Amersham) under standard conditions. The amplified products were analyzed by 1% agarose gel electrophoresis. The 16S rRNA gene was amplified with the primers LA (5′-GGCGGCGCGTCTTAAACATG-3′) and LB (5′-TTCCCCCCATTGAGCAAGATT-3′) [25]. Partial ligB sequences were amplified with the primers PSBF 5′-ACWRVHVHRGYWDCCTGGTCYTCTTC-3′) and PSBR (5′-TARRHDGCYBTAATATYCGRWYYTCCTAA-3′) [26]. Sequencing was performed at the Genotyping of Pathogens and Public Health Platform (Institut Pasteur, Paris, France). The assembled sequence was then aligned against other 16S rRNA sequences available in GenBank using BLAST (http://www.ncbi.nlm.nih.gov/BLAST). Genotyping was also performed by multiple-locus variable-number tandem repeat analysis (MLVA) using the loci VNTR4, VNTR7, VNTR10, Lfb4 and Lfb5 as described by Salaun et al. [27].
For pulsed-field gel electrophoresis (PFGE), cells were embedded in agarose plugs as previously described [28]. DNA plugs were restriction digested with NotI. PFGE was performed in a contour-clamped homogeneous electric field DRIII apparatus (Bio-Rad Laboratories, Richmond, CA). Programs with a ramping from 1 to 70 s for 36 h at 150 V and from 10 to 100 s for 40 h at 150 V were used to resolve of restriction patterns.
Results
Sampling and culture of Leptospira isolates
We used blood sample cultures to investigate patients with febrile illness in Mayotte. We assayed 388 human plasma samples from blood collected in heparin by quantitative real-time PCR between April 2007 and September 2008 (not including serial samples from a same patient). The specific amplification of pathogenic Leptospira spp. was detected in 53 (13,7%) samples ( Figure 2 ). Blood samples from 29 patients diagnosed with leptospirosis (as determined by PCR) were examined by culture. Samples from 26 patients (89.7%) were positive by culture, but leptospires in 4 cultures were lysed on arrival at the National Reference Center of Leptospira (Institut Pasteur). Twenty-two clinical isolates were therefore included in this study. The median time to culture positivity for the primary culture was 19.3 days (7 to 77 days).
Ct values of samples that were positive by culture were between 25.2 and 44.7 (median 34.9) ( Table 1 ). Past experience has shown that prior antimicrobial drug treatment reduces the chances of detecting leptospires in the blood by real-time PCR and culture (data not shown).
We collected demographic and epidemiologic data (age, sex, gender, occupation or hobbies, exposure to water and/or animals) of the twenty-two leptospirosis patients. Many patients were male (77.2%). The median age was 34 (13–78) years old. Patients originated from various locations, illustrating the fact that this disease is distributed across the whole country. Most cases (16/22) occurred during the hot and rainy season from December to April (temperate dry season from May to October). Among the leptospirosis cases with information on occupation (6/22), all had occupations associated with contact with surface water or animals ( Table 1 ).
The clinical manifestations of leptospirosis range from a mild febrile illness to a severe and potentially fatal illness, characterized by jaundice, renal failure, thrombocytopenia, and hemorrhage (Weil's disease). Two patients did not survive. Clinical data generally included fever, myalgia, headache, and elevated bilirubin, creatinine, and transaminase. Patients did not exhibit severe forms of pulmonary leptospirosis.
Serological characterization of clinical isolates
Serological identification of the clinical isolates was performed using the microscopic agglutination test (MAT) method with reference sera that were representative of the major Leptospira serogroups (Text S1). Serogrouping of the 22 isolates revealed agglutination titers for antisera raised against serogroups Mini, Hebdomadis, Pyrogenes, and Grippotyphosa, and negative reactions with antisera raised against the remaining serogroups. The vast majority of isolates (20/22) exhibited high agglutination reactions (400–12,800) with the antiserum raised against serogroup Mini, of which 6/20 also showed detectable agglutination reactions (200–3,200) with the Hebdomadis antiserum. Strains 2008/01774 and 2007/01872 showed a high level of reaction with rabbit antiserum raised against serovars Grippotyphosa and Pyrogenes, respectively ( Table 1 ).
Molecular characterization of clinical isolates
Leptospira isolates were characterized by partial 16S rRNA and ligB sequencing, the amplification of VNTR loci, and PFGE separation of NotI-digested genomic DNA ( Table 1 ). The amplification and sequencing of the 16S rRNA gene (rrs) showed that clinical isolates belong to the pathogenic species L. borgpetersenii (14/22), L. kirschneri (7/22), and L. interrogans (1/22). Sequence analysis of ligB, which is a pathogen-specific gene [26], allowed differentiation below the species level. Thus, L. borgpetersenii isolates are further divided in two different clusters (A and B). The dendrogram showing all ligB genotypes is shown in Figure 3 .
MLVA (Multi Locus VNTR Analysis) has been mainly developed for the pathogens L. interrogans and L. kirschneri [27]. The locus VNTR 7 is not found in L. borgpetersenii; thus, two other loci (Lb4 and Lb5) are usually amplified for typing L. borgpetersenii isolates [27]. The five patterns defined by MLVA are in agreement with the four clusters determined by ligB sequencing ( Table 1 ). None of these genotypes has been previously identified in reference strains when compared to members of serogroups Mini, Hebdomadis, Pyrogenes, and Grippotyphosa [27].
PFGE is the long-standing gold standard method for genotyping Leptospira strains [29], [30], [31]. Tenover et al. [32] proposed PFGE criteria for interpreting the relatedness of epidemiologically related bacterial isolates. In addition, several studies have shown that PFGE profiles for Leptospira strains of a serovar belonging to the same species were indistinguishable or closely related [29], [30], [31]. In this study, isolates were considered different if more than three band differences were observed. Eleven of 21 isolates (52%) generated a common pattern (pattern I) with PFGE separation of NotI-digested genomic DNA. Thus strains isolated from different patients over a one-year period (from April 2007 to June 2008) gave indistinguishable PFGE patterns. The other 10 isolates were grouped into at least six other clusters. Strains 2008/0695, 2008/01926, 2008/03703, the “Grippotyphosa” (strain 2008/01774) and “Pyrogenes” (strain 2007/01872) isolates all displayed a unique PFGE pattern ( Figure 4 ).
MLVA and PFGE patterns were compared against fingerprints from members of serogroups Mini, Hebdomadis, Pyrogenes, and Grippotyphosa, as well as against three african strains belonging to serogroups Grippotyphosa, Sejroe, and Hebdomadis [33], [34] (Text S1).
The PFGE and MLVA patterns obtained for Leptospira clinical isolates that reacted with rabbit antisera raised against serovar Mini were quite different from the patterns obtained for reference strains of the serogroups Hebdomadis (serovars Jules, Nona, Kabura, Kambale, Kremastos, Worsfoldi, and Hebdomadis) and Mini (serovars Mini, Beye, Georgia, Swajizak, Ruparupae, and Tbaquite) ( Figure 4 ). An interesting observation is the similarity of the PFGE reference strain restriction patterns for serovars Jules and Nona (serogroup Hebdomadis), which are L. borgpetersenii isolates of African origin (Text S1) ( Figure 4 ). These two serovars were also indistinguishable by MLVA (data not shown). Similarly, serovars Mini and Swajizak (L. borgpetersenii strains belonging to serogroup Mini) appeared to be closely related based on their PFGE restriction patterns ( Figure 4 ). The “Grippotyphosa” strain displayed a genotype that was different to that displayed by others members of the serogroup Grippotyphosa (serovars Grippotyphosa, Canalzanae, Dadas, Valbuzzi, Vanderhoedeni, Ratnapura, Muelleri, and Liangguang) ( Figures 4 & 5 ). Similarly the “Pyrogenes” strain was different from the MLVA (data not shown) and PFGE ( Figure 4 ) patterns of members that belong to the L. interrogans serogroup Pyrogenes (serovars Pyrogenes, Abramis, Camlo, Guaratuba, Manilae, Robinsoni, Biggis, and Zanoni).
Animal experiments
A representative strain of the major genotype (2007/01203) was tested for virulence in the gerbil infection model of acute leptospirosis [35], [36]. Inoculation with as low as 10 bacteria of strain 2007/01203 induced death in 100% of the animals. Infected gerbils died within 5 to 10 days after the infection ( Figure 6 ). Nasal bleeding was frequently observed in infected animals just before they died. Although gross hemorrhages or jaundice were not detected during necropsy, microscopic foci of hemorrhages were detected in the liver, kidneys, and lungs ( Figure 7 ). Silver impregnation demonstrated a large numbers of spirochetes in the livers, kidneys, and lungs of infected gerbils ( Figure 7 ).
Discussion
The characterization of Leptospira isolates is essential if we are to understand the epidemiological properties of the disease. Leptospira serovars usually demonstrate specific host preferences. For example, rats serve as reservoirs for the serogroup Icterohaemorragiae, whereas house mice are the reservoir for the serogroup Ballum [1]. Local Leptospira isolates may also serve as antigens for the serodiagnosis of leptospirosis. However the isolation of Leptospira from blood specimens is usually rare because of the low sensitivity of the technique, the need for specific medium (EMJH) and a prolonged period of incubation (>1 month) [37]. Infection causes a leptospiremia within the first week of illness until the host mounts an effective acquired immune response, leaving a narrow window in which bacteria can be detected in blood. By screening blood from patients with febrile illness by real-time PCR, we were able to obtain a high rate of isolation of Leptospira. The real-time PCR technique has been shown to provide good sensitivity and a linear relationship between the bacteria copy number and cycle threshold (Ct) values. In this study, blood samples from the two deceased patients exhibited the lowest Ct values (corresponding to 1×105 and 7.7×105 leptospires per ml of blood, respectively) ( Table 1 ). It was previously shown that a density of 104 leptospires per ml of blood is a critical threshold for the vital prognosis of patients [38], [39].
In this study, we isolated 22 strains from the blood of human leptospirosis cases in Mayotte. The isolates were pathogenic to gerbils and were identified by serology and molecular typing. Based on serological data, serogroup Mini appears to be the dominant cause of leptospirosis in Mayotte. However, the first infections due to serogroup Mini were only reported in 2007, as culture isolation techniques were not attempted for logistic reasons in Mayotte before 2007. Prior to 2007, the standard MAT was performed and it did not include the serogroup Mini in its panel of antigens. Over the last ten years (1998–2008), both serological characterization of isolates (since 2007) and serological detection of antibodies in patient sera have shown that the most prevalent Leptospira serogroups in Mayotte have been Sejroe (21%), Grippotyphosa (14%), and Pyrogenes (10%). Serogroup Icterohaemorrhagiae accounted for only 5% of cases (12 of 230 patient sera) (data from the National Reference Center of Leptospira, France). Three isolates were identified as members of the serogroup Mini in 2007 and 16 isolates were identified as members of the serogroup Mini in 2008. In 2009, 84 cases have been diagnosed by PCR, from which 41 positive cultures were identified at the serological level. The most prevalent Leptospira serogroups were Mini (28/41), Pyrogenes (2/41), Pomona (8/41), and Grippotyphosa (1/41).
The serovar Mini was originally isolated from a patient in Italy in 1940. Other serovars were subsequently isolated from humans and animals (opposum, bandicoot, raccon) and classified into the serogroup Mini (Text S1) as a function of their antigenic determinants [18]. Historically, members of serogroup Mini belonged to the larger serogroup Hebdomadis [18]. This serogroup was then divided into three autonomous serogroups: the serogroups Hebdomadis, Mini, and Sejroe. Members of these serogroups may therefore exhibit serological affinities [18] as observed between serogroups Mini and Hebdomadis for some of our clinical isolates ( Table 1 ).
Four molecular typing methods have been used to further characterize the 22 Leptospira clinical isolates. The four molecular typing methods revealed independent polymorphisms ( Table 1 ). 16S ribosomal RNA gene sequence analysis can distinguish leptospiral species, but it is unable to distinguish between serovars. ligB sequencing and MLVA identified four and five genotypes, respectively, whereas PFGE allowed the recognition of subgroups within these genotypes. Thus, PFGE was the best method for discriminating between strains among the tested typing methods; moreover, it showed a strong correlation with the other techniques. However, the rapidity of PCR makes MLVA and ligB sequencing appropriate for the preliminary genotyping of clinical isolates [26], [27].
The pathogens L. borgpetersenii and L. kirschneri were the dominant species among clinical isolates in Mayotte (located between Tanzania and Madagascar). These data are in agreement with previous studies that show that Leptospira isolates from Africa belong to either L. borgpetersenii or L. kirschneri species [33], [34], [40], [41]. By contrast, in other areas, L. interrogans is considered to be the major species responsible for human infections. Interestingly, the serovars belonging to serogroup Mini were found in clinical isolates belonging to both L. borgpetersenii and L. kirschneri. The “serovar” is identified based on structural heterogeneity of the O-antigen, which is the carbohydrate component of the lipopolysaccharide (LPS). Horizontal gene transfer of the LPS locus between different Leptospira species may be responsible for the presence of serovars with serologically related LPS in various species. Thus, the LPS locus of the antigen-related serovars Hardjobovis and Hardjoprajitno belonging to species L. borgpetersenii and L. interrogans, respectively, are highly similar [42].
Genomic macrorestriction with NotI followed by PFGE is considered to be a powerful typing method for classifying Leptospira strains at the serovar level [29], [30], [31], [43]. For example, classification of the Dadas I strain as a new serovar of serogroup Grippotyphosa was strongly supported by its unique pulsed-field gel electrophoresis pattern [43]. The clinical isolates from Mayotte had PFGE patterns that were different to those for the reference strains belonging to serogroups Mini, Hebdomadis, Pyrogenes, and Grippotyphosa (Text S1). These data were confirmed by MLVA. Non tested reference serovars (not present in our collection of strains) include L. weilii serovar Hekou and L. interrogans serovar Perameles [44] from serogroup Mini, L. noguchi serovar Huanaco from serogroup Grippotyphosa, and L. santarosai serovars Borincana, Goiano, Maru, and Sanmartini and the L. alexanderi serovar Manzhuang from the serogroup Hebdomadis [18]. However none of these serovars belong to the identified Leptospira species (i.e. L. borgpetersenii and L. kirschneri) and may therefore be phylogenetically distant from our clinical isolates.
Our findings suggest that clinical isolates belonging to PFGE patterns I to X may represent ten new serovars. These isolates are highly virulent as observed in experimental animals (LD50<10 leptospires for strain 2007/01203) and are associated with severe clinical forms that could lead to death (2 of the 22 patients). These results highlight the potential existence of several undiscovered Leptospira serovars in the Indian Ocean. Further characterization of these isolates should include the use of the cross agglutination absorption tests (CAAT) to determine whether these isolates correspond to previously unknown serovars [45].
A previous survey in Madagascar found no antibodies to leptospirosis or the presence of pathogenic leptospires in possible animal reservoirs or in humans in contact with these animals [46]. Interestingly, patient 20 (a 52 year-old male) reported swimming in a river in Madagascar 10 days prior the onset of symptoms (and no other risk activities during this period). Since the incubation period of the disease is usually 5–14 days, the relationship between symptoms and the water exposure suggests that this traveler acquired the disease in Madagascar, a country with no prior reports of leptospirosis. The strain (2008/03703) isolated from this patient has been grouped with the L. kirschneri serogroup Mini isolates from Mayotte. However, it does exhibit a unique genotype by PFGE ( Table 1 ).
Since the population in Mayotte is primarily of African origin, the epidemiology of leptospirosis in Mayotte may be the result of the introduction of pathogenic strains coming from the neighboring African countries as in the case of the chikungunya [47] and Rift Valley fever [48] outbreaks in Mayotte. Apart from the serogroups Hebdomadis and Grippotyphosa already reported in Africa, there are no references, to our knowledge, to strains belonging to the serogroup Mini in the African continent.
The high incidence of leptospirosis in Mayotte may be explained by the risk of exposure to infected animals. Contact with ruminants (sheep, cattle, or goats) is frequent. Dogs and rats (Rattus rattus; Norway rats or Rattus norvegicus have never been described in Mayotte) are usually encountered in the household area. Mayotte has also an abundance of endemic fauna such as the maki, a type of lemur, and the roussette (flying fox), a large bat. In 1991, cattle, herd, dogs and the common tenrec (Tenrec ecaudatus), a small spiny insectivorous mammal that resembles a hedgehog also found in Madagascar and other islands of the Indian Ocean, were serologically surveyed (88 serum samples) for leptospirosis using MAT [49]. In total, between 50 and 87% of the samples for each group of animals were seropositive for at least one Leptospira serogroup. The most prevalent Leptospira serogroups were Grippotyphosa, Sejroe, Icterohaemorrhagiae, Pyrogenes, and Canicola. Although MAT testing was unable to detect antibodies to Leptospira in the rat sera, a more recent study did detect leptospira (5 positive samples out of 27) in rat kidneys by PCR (unpublished data). These findings demonstrate that these animals are constantly exposed to Leptospira in their environment. The high prevalence of leptospiral infection in animals represents a potential threat to human health.
In summary, we identified 10 potentially new pathogenic Leptospira genotypes. Further ecological and surveillance studies are needed in Mayotte to identify the reservoir host(s) involved in transmission and to determine the public health impact and distribution of pathogenic leptospires in the region.
Supporting Information
Acknowledgments
We are grateful to V. Morel for animal infection experiments and D. Chaumet and F. Zinini for molecular characterization of clinical strains.
Footnotes
The authors have declared that no competing interests exist.
This study was supported by the Institut Pasteur and Institut de Veille Sanitaire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14:296–326. doi: 10.1128/CMR.14.2.296-326.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.McBride AJ, Athanazio DA, Reis MG, Ko AI. Leptospirosis. Curr Opin Infect Dis. 2005;18:376–386. doi: 10.1097/01.qco.0000178824.05715.2c. [DOI] [PubMed] [Google Scholar]
- 3.Kuriakose M, Paul R, Joseph MR, Sugathan S, Sudha TN. Leptospirosis in a midland rural area of Kerala State. Indian J Med Res. 2008;128:307–312. [PubMed] [Google Scholar]
- 4.Lacerda HG, Monteiro GR, Oliveira CC, Suassuna FB, Queiroz JW, et al. Leptospirosis in a subsistence farming community in Brazil. Trans R Soc Trop Med Hyg. 2008;102:1233–1238. doi: 10.1016/j.trstmh.2008.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ko AI, Galvao Reis M, Ribeiro Dourado CM, Johnson WDJ, Riley LW. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet. 1999;354:820–825. doi: 10.1016/s0140-6736(99)80012-9. [DOI] [PubMed] [Google Scholar]
- 6.Riley LW, Ko AI, Unger A, Reis MG. Slum health: diseases of neglected populations. BMC Int Health Hum Rights. 2007;7:2. doi: 10.1186/1472-698X-7-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Reis RB, Ribeiro GS, Felzemburgh RD, Santana FS, Mohr S, et al. Impact of environment and social gradient on leptospira infection in urban slums. PLoS Negl Trop Dis. 2008;2:e228. doi: 10.1371/journal.pntd.0000228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Trevejo RT, Rigau-Perez JG, Ashford DA, McClure EM, Jarquin-Gonzalez C, et al. Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis. 1998;178:1457–1463. doi: 10.1086/314424. [DOI] [PubMed] [Google Scholar]
- 9.Pappas G, Papadimitriou P, Siozopoulou V, Christou L, Akritidis N. The globalization of leptospirosis: worldwide incidence trends. Int J Infect Dis. 2008;12:351–357. doi: 10.1016/j.ijid.2007.09.011. [DOI] [PubMed] [Google Scholar]
- 10.Tassinari WS, Pellegrini DC, Sá CB, Reis RB, Ko AI, et al. Detection and modelling of case clusters for urban leptospirosis. Trop Med Int Health. 2008;13:503–512. doi: 10.1111/j.1365-3156.2008.02028.x. [DOI] [PubMed] [Google Scholar]
- 11.Sanders EJ, Rigau-Perez JG, Smits HL, Deseda CC, Vorndam VA, et al. Increase of leptospirosis in dengue-negative patients after a hurricane in Puerto Rico in 1966. Am J Trop Med Hyg. 1999;61:399–404. doi: 10.4269/ajtmh.1999.61.399. [DOI] [PubMed] [Google Scholar]
- 12.Salud OPdl. El Fenómeno El Niño en Ecuador. Fenómeno El Niño, 1997–1998. Washington, D.C.: Organización Panamericana de la Salud; 2000. 294 [Google Scholar]
- 13.Storck CH, Postic D, Lamaury IP, J.M. Changes in epidemiology of leptospirosis in 2003–2004, a two El Niño Southern Oscillation period, Guadeloupe archipelago, French West Indies. Epidemiol Infect. 2008;136:1407–1415. doi: 10.1017/S0950268807000052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Morgan J, Bornstein SL, Karpati AM, Bruce M, Bolin CA, et al. Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clinical Infectious Diseases. 2002;34:1593–1599. doi: 10.1086/340615. [DOI] [PubMed] [Google Scholar]
- 15.Sejvar J, Bancroft E, Winthrop K, Bettinger J, Bajani M, et al. Leptospirosis in “Eco-Challenge” athletes, Malaysian Borneo, 2000. Emerg Infect Dis. 2003;9:702–707. doi: 10.3201/eid0906.020751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.WHO. Leptospirosis worldwide, 1999. Weekly Epidemiol Rec. 1999;74:237–242. [PubMed] [Google Scholar]
- 17.Laporte P, Michault A, Galtier J, Lefait-Robin R, Aucher P, et al. Leptospirosis in Mayotte. Bull Soc Pathol Exot. 1990;83:637–641. [PubMed] [Google Scholar]
- 18.Kmety E, Dikken H. Classification of the species Leptospira interrogans and history of its serovars. Groningen Netherlands: University Press; 1993. [Google Scholar]
- 19.Cerqueira GM, Picardeau M. A century of Leptospira strain typing. Infect Genet Evol. 2009;9:760–768. doi: 10.1016/j.meegid.2009.06.009. [DOI] [PubMed] [Google Scholar]
- 20.Ellinghausen HC, McCullough WG. Nutrition of Leptospira pomona and growth of 13 other serotypes: fractionation of oleic albumin complex and a medium of bovine albumin and polysorbate 80. Am J Vet Res. 1965;26:45–51. [PubMed] [Google Scholar]
- 21.Johnson RC, Rogers FC. Differentiation of pathogenic and saprophytic leptospires with 8-azaguanine. J Bacteriol. 1964;88:1618–1623. doi: 10.1128/jb.88.6.1618-1623.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Dikken H, Kmety E. In: Serological typing methods of leptospires. Bergan T, Norris JR, editors. Methods in Microbiology, London: Academic Press; 1978. pp. 259–307. [Google Scholar]
- 23.Ristow P, Bourhy P, da Cruz McBride FW, Figueira CP, Huerre M, et al. The OmpA-like protein Loa22 is essential for leptospiral virulence. PLoS Pathog. 2007;3:e97. doi: 10.1371/journal.ppat.0030097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Smythe LD, Smith IL, Smith GA, Dohnt MF, Symonds ML, et al. A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp. BMC Infect Dis. 2002;8:13. doi: 10.1186/1471-2334-2-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Mérien F, Amouriaux P, Perolat P, Baranton G, Saint Girons I. Polymerase chain reaction for detection of Leptospira spp. in clinical samples. J Clin Microbiol. 1992;30:2219–2224. doi: 10.1128/jcm.30.9.2219-2224.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Cerqueira GM, McBride AJ, Picardeau M, Ribeiro SG, Moreira AN, et al. Distribution of the Leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp. and application of ligB to typing leptospiral isolates. J Med Microbiol. 2009 doi: 10.1099/jmm.0.009175-0. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Salaün L, Mérien F, Gurianova S, Baranton G, Picardeau M. Application of multilocus variable-number tandem-repeat analysis for molecular typing of the agent of leptospirosis. J Clin Microbiol. 2006;44:3954–3962. doi: 10.1128/JCM.00336-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Davidson BE, MacDougall J, Saint Girons I. Physical map of the linear chromosome of the bacterium Borrelia burgdorferi 212, a causative agent of Lyme disease, and localization of rRNA genes. J Bacteriol. 1992;174:3766–3774. doi: 10.1128/jb.174.11.3766-3774.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Herrmann JL, Bellenger E, Perolat P, Baranton G, Saint Girons I. Pulsed-field gel electrophoresis of NotI digests of leptospiral DNA: a new rapid method of serovar identification. J Clin Microbiol. 1992;30:1696–1702. doi: 10.1128/jcm.30.7.1696-1702.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Zuerner R, Herrmann JL, Saint Girons I. Construction and comparison of genetic maps for two Leptospira interrogans serovars provides evidence for two chromosomes and intraspecies heterogeneity in genomic organization. J Bacteriol. 1993;175:5445–5451. doi: 10.1128/jb.175.17.5445-5451.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Galloway RL, Levett PN. Evaluation of a modified pulsed-field gel electrophoresis approach for the identification of Leptospira serovars. Am J Trop Med Hyg. 2008;78:628–632. [PubMed] [Google Scholar]
- 32.Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–2239. doi: 10.1128/jcm.33.9.2233-2239.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Feresu SB, Steigerwalt AG, Brenner DJ. DNA relatedness of Leptospira strains isolated from beef cattle in Zimbabwe. Int J Syst Bacteriol. 1999;49:1111–1117. doi: 10.1099/00207713-49-3-1111. [DOI] [PubMed] [Google Scholar]
- 34.Feresu SB, Korver H, Riquelme N, Baranton G, Bolin CA. Two new leptospiral serovars in the Hebdomadis serogroup isolated from Zimbabwe cattle. Int J Syst Bacteriol. 1996;46:694–698. doi: 10.1099/00207713-46-3-694. [DOI] [PubMed] [Google Scholar]
- 35.Sonrier C, Branger C, Michel V, Ruvoën-Clouet N, Ganière JP, et al. Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine. 2000;15:86–94. doi: 10.1016/s0264-410x(00)00129-8. [DOI] [PubMed] [Google Scholar]
- 36.Yukawa M, Mochizuki K, Imamura S. Susceptibility of Mongolian gerbils (Meriones unguiculatus) to leptospires and the protective effect of vaccination. Vet Microbiol. 1990;24:63–71. doi: 10.1016/0378-1135(90)90051-v. [DOI] [PubMed] [Google Scholar]
- 37.Wuthiekanun V, Chierakul W, Limmathurotsakul D, Smythe LD, Symonds ML, et al. Optimization of culture of Leptospira from humans with leptospirosis. J Clin Microbiol. 2007;45:1363–1365. doi: 10.1128/JCM.02430-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Truccolo J, Serais O, Merien F, Perolat P. Following the course of human leptospirosis: evidence of a critical threshold for the vital prognosis using a quantitative PCR assay. FEMS Microbiol Lett. 2001;204:17–321. doi: 10.1111/j.1574-6968.2001.tb10904.x. [DOI] [PubMed] [Google Scholar]
- 39.Segura ER, Ganoza CA, Campos K, Ricaldi JN, Torres S, et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis. 2005;40:343–351. doi: 10.1086/427110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Brenner DJ, Kaufmann AF, Sulzer KR, Steigerwalt AG, Rogers FC, et al. Further determination of DNA relatedness between serogroups and serovars in the family Leptospiraceae witha proposal for Leptospira alexanderi sp. nov. and four new Leptospira genomospecies. Int J Syst Bacteriol. 1999;49:839–858. doi: 10.1099/00207713-49-2-839. [DOI] [PubMed] [Google Scholar]
- 41.Mgode GF, Machang'u RS, Goris MG, Engelbert M, Sondij S, et al. New Leptospira serovar Sokoine of serogroup Icterohaemorrhagiae from cattle in Tanzania. Int J Syst Evol Microbiol. 2006;56:593–597. doi: 10.1099/ijs.0.63278-0. [DOI] [PubMed] [Google Scholar]
- 42.De la Peña-Moctezuma A, Bulach DM, Kalambaheti T, Adler B. Comparative analysis of the LPS biosynthetic loci of the genetic subtypes of serovar Hardjo: Leptospira interrogans subtype Hardjoprajitno and Leptospira borgpetersenii subtype Hardjobovis. . FEMS Microbiol Lett. 1999;177:319–326. doi: 10.1111/j.1574-6968.1999.tb13749.x. [DOI] [PubMed] [Google Scholar]
- 43.Herrmann JL, Bakoss P, Korver H, Bulu AA, Bellenger E, et al. A new serovar in the Grippotyphosa serogroup comprising leptospiral isolates from different regions. Int J Syst Bacteriol. 1994;44:362–364. doi: 10.1099/00207713-44-2-362. [DOI] [PubMed] [Google Scholar]
- 44.Slack AT, Galloway RL, Symonds ML, Dohnt MF, Smythe LD. Reclassification of Leptospira meyeri serovar Perameles to Leptospira interrogans serovar Perameles through serological and molecular analysis: evidence of a need for changes to current procedures in Leptospira taxonomy. Int J Syst Evol Microbiol. 2009;59:1199–1203. doi: 10.1099/ijs.0.000992-0. [DOI] [PubMed] [Google Scholar]
- 45.Faine S, Adler B, Bolin C, Perolat P. Leptospira and leptospirosis. Melbourne, Australia: MedScience; 1999. [Google Scholar]
- 46.Ralaiarijaona RL, Bellenger E, Chanteau S, Roger F, Pérolat P, et al. Detection of leptospirosis reservoirs in Madagascar using the polymerase chain reaction technique. Arch Inst Pasteur Madagascar. 2001;67:34–36. [PubMed] [Google Scholar]
- 47.Sergon K, Njuguna C, Kalani R, Ofula V, Onyango C, et al. Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg. 2008;78:333–337. [PubMed] [Google Scholar]
- 48.Sissoko D, Giry C, Gabrie P, Tarantola A, Pettinelli F, et al. Rift Valley fever, Mayotte, 2007–2008. Emerg Infect Dis. 2009;15:568–570. doi: 10.3201/eid1504.081045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Charton A. Contribution à l'étude épidémiologique des leptospiroses: le cas de l'île de Mayotte. 1992. PhD Thesis. Ecole Vétérinaire de Lyon. Lyon.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.